Reviewed,
UniProtKB/Swiss-Prot Q99490 (AGAP2_HUMAN)
Last modified
June 16, 2009.
Version 106.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Arf-GAP, GTPase, ANK repeat and PH domain-containing protein 2 Short name=AGAP-2 Alternative name(s): Centaurin-gamma-1 Phosphatidylinositol-3-kinase enhancer Short name=PIKE GTP-binding and GTPase-activating protein 2 Short name=GGAP2 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1192 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | GTPase-activating protein (GAP) for ARF1 and ARF5, which also shows strong GTPase activity. Isoform 1 participates in the prevention of neuronal apoptosis by enhancing PI3 kinase activity. It aids the coupling of metabotropic glutamate receptor 1 (GRM1) to cytoplasmic PI3 kinase by interacting with Homer scaffolding proteins, and also seems to mediate anti-apoptotic effects of NGF by activating nuclear PI3 kinase. Isoform 2 does not stimulate PI3 kinase but may protect cells from apoptosis by stimulating Akt. It also regulates the adapter protein 1 (AP-1)-dependent trafficking of proteins in the endosomal system. Ref.3 Ref.8 Ref.9 Ref.10 |
| Enzyme regulation | GAP activity is stimulated by phosphatidylinositol 4,5-bisphosphate (PIP2) and, to a lesser extent, by phosphatidylinositol 3,4,5-trisphosphate (PIP3). Phosphatidic acid potentiates PIP2 stimulation. |
| Subunit structure | Isoform 1 interacts with EPB41L1, PLCG1, NF2, HOMER1 and HOMER2 By similarity. Isoform 2 interacts with activated AKT1 in the presence of guanine nucleotides, and with the AP-1 complex. |
| Subcellular location | |
| Tissue specificity | Isoform 1 is brain-specific. Isoform 2 is ubiquitously expressed, with highest levels in brain and heart. Ref.3 Ref.8 Ref.9 Ref.10 Ref.11 |
| Domain | G domain binds GTP and has GTPase activity. Arf-GAP domain interacts with G domain and may regulate its GTPase activity. Although both PH domains of isoforms 1 and 2 bind phospholipids, they differently regulate subcellular location. PH domain of isoform 1 directs the protein to the nucleus, but PH domain of isoform 2 directs it to the cytosol. PH domain of isoform 2 is required for binding to AP-1. |
| Miscellaneous | Isoform 2 seems to be oncogenic. It is overexpressed in cancer cells, prevents apoptosis and promotes cancer cell invasion. |
| Sequence similarities | Belongs to the centaurin gamma-like family. Contains 2 ANK repeats. Contains 1 Arf-GAP domain. Contains 1 PH domain. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q99490-1) Also known as: PIKE-L; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q99490-2) Also known as: PIKE-A; The sequence of this isoform differs from the canonical sequence as follows: 1-336: Missing. 337-390: ASTRDRKMLK...LGAELRASPK → MHAQRQFVVA...IQASLDSIRE 853-872: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1192 | 1192 | Arf-GAP, GTPase, ANK repeat and PH domain-containing protein 2 | PRO_0000074217 | ||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 676 – 910 | 235 | PH | |||||||||||||||||||||||||||||||||||||||||||||
| Domain | 931 – 1051 | 121 | Arf-GAP | |||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 1090 – 1119 | 30 | ANK 1 | |||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 1123 – 1152 | 30 | ANK 2 | |||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 413 – 420 | 8 | GTP Potential | |||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 457 – 461 | 5 | GTP Potential | |||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 515 – 518 | 4 | GTP Potential | |||||||||||||||||||||||||||||||||||||||||||||
| Zinc finger | 946 – 969 | 24 | C4-type | |||||||||||||||||||||||||||||||||||||||||||||
| Region | 1 – 23 | 23 | Interaction with EPB41L1 By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Region | 180 – 225 | 46 | Interactions with HOMER1 and NF2 By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Region | 267 – 390 | 124 | Interaction with PLCG1 By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Region | 405 – 572 | 168 | G domain | |||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 149 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 267 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 638 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 808 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 865 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 927 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 336 | 336 | Missing in isoform 2. | VSP_018531 | ||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 337 – 390 | 54 | ASTRD…RASPK → MHAQRQFVVAAVRAEVRRHE VAKQALNRLRKLAERVDDPE LQDSIQASLDSIRE in isoform 2. | VSP_018532 | ||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 853 – 872 | 20 | Missing in isoform 2. | VSP_018533 | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 339 | 1 | T → A in a breast cancer sample; somatic mutation. Ref.14 | VAR_036183 | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 455 | 1 | V → A in a glioblastoma cell line. Ref.13 | VAR_026438 | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 507 | 1 | G → S: dbSNP rs2301553. | VAR_022046 | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 518 | 1 | R → G in a sarcoma cell line. Ref.13 | VAR_026439 | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 568 | 1 | T → I in a neuroblastoma cell line. Ref.13 | VAR_026440 | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 651 | 1 | A → V in a glioblastoma cell line. Ref.13 | VAR_026441 | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 767 | 1 | E → V in a glioblastoma cell line. Ref.13 | VAR_026442 | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 816 | 1 | D → Y in a breast cancer sample; somatic mutation. Ref.14 | VAR_036184 | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 939 | 1 | N → D in a glioblastoma cell line. Ref.13 | VAR_026443 | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 947 | 1 | V → M in a sarcoma cell line. Ref.13 | VAR_026444 | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 1022 | 1 | S → P in a glioblastoma cell line. Ref.13 | VAR_026445 | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 1124 | 1 | G → V: dbSNP rs238521. | VAR_055532 | ||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1137 | 1 | Q → H in AAC39522. Ref.1 | |||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1147 | 1 | G → A in AAC39522. Ref.1 | |||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 406 – 412 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 415 – 418 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 419 – 428 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 440 – 448 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 451 – 459 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 466 – 471 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 473 – 480 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 484 – 500 | 17 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 509 – 515 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 521 – 523 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 529 – 537 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 542 – 548 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 549 – 552 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 555 – 575 | 21 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 677 – 686 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 695 – 703 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 704 – 706 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 707 – 713 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 714 – 719 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 724 – 730 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 732 – 734 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 765 – 768 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Transcript mapping in a 46-kb sequenced region at the core of 12q13.3 amplification in human cancers." Elkahloun A.G., Krizman D.B., Wang Z., Hofmann T.A., Roe B.A., Meltzer P.S. Genomics 42:295-301(1997) [PubMed: 9192850] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORM 2), VARIANT VAL-1124. |
| [2] | Roe B. Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases Cited for: SEQUENCE REVISION TO 389; 768-769; 1124; 1137 AND 1147 (ISOFORM 2). |
| [3] | "GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins." Xia C., Ma W., Stafford L.J., Liu C., Gong L., Martin J.F., Liu M. Mol. Cell. Biol. 23:2476-2488(2003) [PubMed: 12640130] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, SUBCELLULAR LOCATION, FUNCTION. Tissue: Heart. |
| [4] | "PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis." Rong R., Ahn J.-Y., Huang H., Nagata E., Kalman D., Kapp J.A., Tu J., Worley P.F., Snyder S.H., Ye K. Nat. Neurosci. 6:1153-1161(2003) [PubMed: 14528310] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [5] | "Kiaa0167 as a member (centaurin gamma1) of centaurin ArfGAP family." Hong W. Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). |
| [6] | "Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1." Nagase T., Seki N., Ishikawa K., Tanaka A., Nomura N. DNA Res. 3:17-24(1996) [PubMed: 8724849] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Bone marrow. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Blood. |
| [8] | "PIKE (phosphatidylinositol 3-kinase enhancer)-A GTPase stimulates Akt activity and mediates cellular invasion." Ahn J.-Y., Rong R., Kroll T.G., Van Meir E.G., Snyder S.H., Ye K. J. Biol. Chem. 279:16441-16451(2004) [PubMed: 14761976] [Abstract] Cited for: TISSUE SPECIFICITY, SUBCELLULAR LOCATION, INTERACTION WITH AKT1, FUNCTION. |
| [9] | "PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt." Ahn J.-Y., Hu Y., Kroll T.G., Allard P., Ye K. Proc. Natl. Acad. Sci. U.S.A. 101:6993-6998(2004) [PubMed: 15118108] [Abstract] Cited for: TISSUE SPECIFICITY, INTERACTION WITH AKT1, FUNCTION. |
| [10] | "The Arf GAPs AGAP1 and AGAP2 distinguish between the adaptor protein complexes AP-1 and AP-3." Nie Z., Fei J., Premont R.T., Randazzo P.A. J. Cell Sci. 118:3555-3566(2005) [PubMed: 16079295] [Abstract] Cited for: TISSUE SPECIFICITY, INTERACTION WITH THE AP-1 COMPLEX, FUNCTION. |
| [11] | "Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas." Knobbe C.B., Trampe-Kieslich A., Reifenberger G. Neuropathol. Appl. Neurobiol. 31:486-490(2005) [PubMed: 16150119] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [12] | "Crystal structure of centaurin gamma 1." Yang X., Elkins J.M., Soundararajan M., Doyle D.A. Submitted (MAR-2005) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF N-TERMINUS (ISOFORM 2). |
| [13] | "Phosphoinositol lipids bind to phosphatidylinositol 3 (PI3)-kinase enhancer GTPase and mediate its stimulatory effect on PI3-kinase and Akt signalings." Hu Y., Liu Z., Ye K. Proc. Natl. Acad. Sci. U.S.A. 102:16853-16858(2005) [PubMed: 16263930] [Abstract] Cited for: VARIANTS ALA-455; GLY-518; ILE-568; VAL-651; VAL-767; ASP-939; MET-947 AND PRO-1022, SUBCELLULAR LOCATION. |
| [14] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed: 16959974] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] ALA-339 AND TYR-816. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U81031 Genomic DNA. Translation: AAC39522.2. AF384128 mRNA. Translation: AAO39848.1. AY128689 mRNA. Translation: AAM97540.1. D79989 mRNA. Translation: BAA11484.2. Different initiation. AF413077 mRNA. Translation: AAL04171.1. BC028020 mRNA. Translation: AAH28020.1. | |||||||||||||||||||||||||
| IPI | IPI00015401. IPI00217393. | ||||||||||||||||||||||||
| RefSeq | NP_001116244.1. NP_055585.1. | ||||||||||||||||||||||||
| UniGene | Hs.302435 | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | Q99490. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PRIDE | Q99490. | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENSG00000135439. Homo sapiens. [Contig view] | ||||||||||||||||||||||||
| GeneID | 116986. | ||||||||||||||||||||||||
| KEGG | hsa:116986. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| GeneCards | GC12M056406. | ||||||||||||||||||||||||
| H-InvDB | HIX0010751. HIX0036788. | ||||||||||||||||||||||||
| HGNC | HGNC:16921. AGAP2. | ||||||||||||||||||||||||
| MIM | 605476. gene. | ||||||||||||||||||||||||
| PharmGKB | PA26411. | ||||||||||||||||||||||||
| HUGE | Search... | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| HOGENOM | Q99490. | ||||||||||||||||||||||||
| HOVERGEN | Q99490. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Pathway_Interaction_DB | pi3kplctrkpathway. Trk receptor signaling mediated by PI3K and PLC-gamma. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | Q99490. | ||||||||||||||||||||||||
| Bgee | Q99490. | ||||||||||||||||||||||||
| CleanEx | HS_AGAP2. | ||||||||||||||||||||||||
| GermOnline | ENSG00000135439. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR002110. ANK. IPR001164. ArfGAP. IPR013684. Miro-like. IPR001849. Pleckstrin_homology. [Graphical view] | ||||||||||||||||||||||||
| Gene3D | G3DSA:1.25.40.20. ANK. 1 hit. | ||||||||||||||||||||||||
| Pfam | PF00023. Ank. 2 hits. PF01412. ArfGap. 1 hit. PF08477. Miro. 1 hit. PF00169. PH. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PRINTS | PR00405. REVINTRACTNG. | ||||||||||||||||||||||||
| SMART | SM00248. ANK. 2 hits. SM00105. ArfGap. 1 hit. SM00233. PH. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PROSITE | PS50297. ANK_REP_REGION. 1 hit. PS50088. ANK_REPEAT. 1 hit. PS50115. ARFGAP. 1 hit. PS50003. PH_DOMAIN. 1 hit. PS51419. RAB. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||
| NextBio | 80070. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | AGAP2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q99490 Secondary accession number(s): O00578, Q548E0, Q8IWU3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


